Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

OKI And Hitachi To Launch Joint Venture For ATM And Automated Equipment In October

OKI, Hitachi, and Hitachi Channel Solutions have announced that they have reached agreements to integrate their automat... Read more

The Race For Hong Kongs First Stablecoin Licenses Is Almost Over

I’ve been refreshing the Hong Kong Monetary Authority’s register of licensed stablecoin issuers frequently over the... Read more

HTF Securities And Alchemy Pay Expand Hong Kong Type 1 License For Virtual Assets

Alchemy Pay has announced that, in partnership with HTF Securities Limited, it has successfully expanded HTF Securities... Read more

Ping An Digital Bank Rebrands As Deposits Exceed HK$12 Billion

Ping An Digital Bank has introduced a new brand identity, aligning more closely with its parent, Ping An Insurance. The... Read more

Futus PantherTrade Launches Full-Scale Licensed Operations In Hong Kong

Futu has announced that its wholly-owned virtual asset trading platform, PantherTrade, has begun full-scale licensed op... Read more

Mastercard Enables AI Agent To Complete Live Ride-Booking Payment In South Korea

Mastercard has completed a live, authenticated agentic transaction in South Korea, marking a key development in AI-powe... Read more